BALCAO · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Glucose Health, Inc. GLUC
7 fiscal years on record · USD · FY2016 reported · SEC filings only
$-410,443
Growth
USD 313,229.00
Revenue, FY2016 · full 7-year series below
Revenue $M
Net income $M
FY2016 · Revenue 0.3 · Net income -0.4
Compound annual growth
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−131 cents
lost on every revenue dollar
Operating margin
Net margin
FY2016 · Operating -27.7% · Net -131.0%
ROE
Not applicable: equity was negative in this period, so return on equity has no meaning.
The 7-year record
7 fiscal years
Every figure from documents filed with the SEC · USD
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative
| Metric | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 | · | · | 0.0 |
| Operating income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA $B | · | · | · | · | · | · | · |
| Income tax $B | · | · | · | · | · | · | · |
| Net income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −0.15 | −0.14 | −0.99 | −4.91 | −0.05 | −0.02 | −0.03 |
| Dividend / sh $ | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · |
| ROE % | · | · | · | · | · | · | · |
| Shares out B | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.07 | 0.02 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 33 reconciliationsAUDITED
Reconciled in 7 of 19 fiscal years. 62 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityMedicinal Chemicals & Botanical Products
Listed onOTC market
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2010